Moors & Cabot’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $582K | Buy |
21,087
+800
| +4% | +$22.1K | 0.03% | 474 |
|
2025
Q1 | $575K | Sell |
20,287
-36,136
| -64% | -$1.02M | 0.03% | 446 |
|
2024
Q4 | $2.35M | Buy |
56,423
+1,954
| +4% | +$81.2K | 0.11% | 161 |
|
2024
Q3 | $3.64M | Buy |
54,469
+8,390
| +18% | +$561K | 0.18% | 110 |
|
2024
Q2 | $5.47M | Buy |
46,079
+110
| +0.2% | +$13.1K | 0.29% | 72 |
|
2024
Q1 | $4.9M | Buy |
45,969
+5,919
| +15% | +$631K | 0.27% | 86 |
|
2023
Q4 | $3.98M | Buy |
40,050
+12,149
| +44% | +$1.21M | 0.25% | 90 |
|
2023
Q3 | $2.88M | Sell |
27,901
-7,007
| -20% | -$724K | 0.2% | 115 |
|
2023
Q2 | $4.24M | Sell |
34,908
-1,139
| -3% | -$138K | 0.28% | 84 |
|
2023
Q1 | $5.54M | Sell |
36,047
-271
| -0.7% | -$41.6K | 0.38% | 55 |
|
2022
Q4 | $6.52M | Sell |
36,318
-505
| -1% | -$90.7K | 0.45% | 42 |
|
2022
Q3 | $4.35M | Sell |
36,823
-314
| -0.8% | -$37.1K | 0.33% | 73 |
|
2022
Q2 | $5.31M | Buy |
37,137
+334
| +0.9% | +$47.7K | 0.38% | 57 |
|
2022
Q1 | $6.34M | Sell |
36,803
-1,220
| -3% | -$210K | 0.39% | 56 |
|
2021
Q4 | $9.66M | Sell |
38,023
-1,070
| -3% | -$272K | 0.59% | 33 |
|
2021
Q3 | $15M | Sell |
39,093
-6,731
| -15% | -$2.59M | 0.94% | 18 |
|
2021
Q2 | $10.8M | Sell |
45,824
-408
| -0.9% | -$95.9K | 0.76% | 19 |
|
2021
Q1 | $6.05M | Buy |
46,232
+546
| +1% | +$71.5K | 0.46% | 50 |
|
2020
Q4 | $4.77M | Buy |
45,686
+315
| +0.7% | +$32.9K | 0.4% | 59 |
|
2020
Q3 | $3.21M | Sell |
45,371
-3,810
| -8% | -$270K | 0.3% | 80 |
|
2020
Q2 | $3.15M | Sell |
49,181
-13,438
| -21% | -$862K | 0.34% | 72 |
|
2020
Q1 | $1.88M | Buy |
62,619
+13,000
| +26% | +$389K | 0.27% | 88 |
|
2019
Q4 | $980K | Buy |
49,619
+9,900
| +25% | +$196K | 0.1% | 213 |
|
2019
Q3 | $632K | Buy |
39,719
+8,200
| +26% | +$130K | 0.07% | 273 |
|
2019
Q2 | $456K | Buy |
+31,519
| New | +$456K | 0.06% | 318 |
|